Calcium Replacement After Blood Transfusion
Pathophysiology of Transfusion-Related Hypocalcemia
- Hypocalcemia during blood transfusion results from citrate-mediated chelation of serum calcium, as each unit of packed red blood cells (pRBC) or fresh frozen plasma (FFP) contains approximately 3g of citrate used as a preservative and anticoagulant 1
- Citrate is normally metabolized by the liver to bicarbonate within minutes, but this process is impaired during hemorrhagic shock due to liver hypoperfusion 1
- Ionized calcium is essential for coagulation cascade function, acting as a cofactor in the activation of factors II, VII, IX, X, and proteins C and S, as well as for platelet adhesion 1
Monitoring Recommendations
- Monitor ionized calcium levels in all patients receiving blood transfusions, especially during massive transfusion 1, 2
- Normal ionized calcium range is 1.1-1.3 mmol/L and is pH-dependent (a 0.1 unit increase in pH decreases ionized calcium by approximately 0.05 mmol/L) 1, 2
Treatment Recommendations
- Calcium chloride is the preferred agent for treatment of hypocalcemia during and after blood transfusion 1, 2
- 10 mL of 10% calcium chloride solution contains 270 mg of elemental calcium, compared to only 90 mg in 10 mL of 10% calcium gluconate 1, 2
- Calcium chloride is more effective than calcium gluconate in patients with liver dysfunction due to faster release of ionized calcium 1, 2
Dosing Strategy
- Maintain ionized calcium levels above 0.9 mmol/L to support cardiovascular function and coagulation 2
- Promptly correct hypocalcemia when ionized calcium levels fall below 0.9 mmol/L or when total corrected calcium levels are ≤7.5 mg/dL 1, 2
Potential Complications
- Hypocalcemia within the first 24 hours of critical bleeding can predict mortality and need for multiple transfusions with greater accuracy than the lowest fibrinogen concentration, acidosis, and lowest platelet count 1
- Ionized calcium levels below 0.8 mmol/L are associated with cardiac dysrhythmias 1
- Low ionized calcium levels at admission are associated with increased mortality, need for massive transfusion, platelet dysfunction, decreased clot strength, and coagulopathy 2